(Q82464453)

English

Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: report of a case

scientific article published on 12 November 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: report of a case (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

based on heuristic

inferred from title

author name string

Yoshiro Itatani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Takashi Akiyoshi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hiroya Kuroyanagi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Keiko Yamakawa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rota Noaki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tsuyoshi Konishi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yoshiya Fujimoto

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Masashi Ueno

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Masatoshi Oya

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mitsukuni Suenaga

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Toshiharu Yamaguchi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

12 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

75-79

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent concepts of antiangiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No downstaging after short-term preoperative radiotherapy in rectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the role for the circumferential margin in the modern treatment of rectal cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapy in rectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circumferential Margin Involvement Is the Crucial Prognostic Factor after Multimodality Treatment in Patients with Locally Advanced Rectal Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refining multimodal therapy for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

1 reference

https://pubmed.ncbi.nlm.nih.gov/22075663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00595-011-0004-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075663%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82464453&oldid=2038014675"